| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-01-03 | Deutsch Todd | AIM ImmunoTech Inc. | 1,716,100 | 3.5% | EDGAR |
| SC 13D/A | 2023-08-28 | Deutsch Todd | AIM ImmunoTech Inc. | 1,716,100 | 3.5% | EDGAR |
| SC 13D/A | 2023-08-07 | Deutsch Todd | AIM ImmunoTech Inc. | 1,716,100 | 3.5% | EDGAR |
| SC 13D | 2023-07-27 | Deutsch Todd | AIM ImmunoTech Inc. | 1,716,100 | 3.5% | EDGAR |
| SC 13G/A | 2021-02-08 | Hudson Bay Capital Management LP | AIM ImmunoTech Inc. | 7,747 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Anson Funds Management LP | AIM ImmunoTech Inc. | 434,030 | 4.9% | EDGAR |
| SC 13G | 2020-01-31 | Hudson Bay Capital Management LP | AIM ImmunoTech Inc. | 917,198 | 10.0% | EDGAR |
| SC 13G | 2019-09-30 | Anson Funds Management LP | AIM ImmunoTech Inc. | 1,277,222 | 9.9% | EDGAR |
| SC 13D | 2019-06-28 | EQUELS THOMAS K. | HEMISPHERX BIOPHARMA INC | 120,498 | 5.3% | EDGAR |
| SC 13D/A | 2019-06-18 | EQUELS THOMAS K. | HEMISPHERX BIOPHARMA INC | 387,891,414 | 4.2% | EDGAR |
| SC 13D | 2019-04-09 | EQUELS THOMAS K. | HEMISPHERX BIOPHARMA INC | 3,976,414 | 5.9% | EDGAR |
| SC 13G | 2019-04-05 | Iliad Research & Trading, L.P. | HEMISPHERX BIOPHARMA INC | 6,222,802 | 10.0% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | HEMISPHERX BIOPHARMA INC | 1,250,000 | 2.6% | EDGAR |
| SC 13G | 2018-04-24 | SABBY MANAGEMENT, LLC | HEMISPHERX BIOPHARMA INC | 500,000 | 1.1% | EDGAR |
| SC 13G/A | 2018-01-05 | SABBY MANAGEMENT, LLC | HEMISPHERX BIOPHARMA INC | 1,584,885 | 5.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Anson Funds Management LP | HEMISPHERX BIOPHARMA INC | 1,226,851 | 4.9% | EDGAR |
| SC 13G/A | 2017-01-11 | SABBY MANAGEMENT, LLC | HEMISPHERX BIOPHARMA INC | 850,769 | 3.5% | EDGAR |
| SC 13G | 2016-09-07 | Frigate Ventures LP | HEMISPHERX BIOPHARMA INC | 1,666,667 | 6.9% | EDGAR |
| SC 13G | 2016-09-01 | SABBY MANAGEMENT, LLC | HEMISPHERX BIOPHARMA INC | 1,000,000 | 4.2% | EDGAR |
| SC 13G | 2009-05-28 | KOPIN MITCHELL P | HEMISPHERX BIOPHARMA INC | 5,953,488 | 5.4% | EDGAR |